Back to Journals » Journal of Hepatocellular Carcinoma » Volume 12 » default
Journal of Hepatocellular Carcinoma
- View all (1026)
- Volume 13, 2026 (101)
- Volume 12, 2025 (220)
- Volume 11, 2024 (181)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Archive: Volume 12, 2025
- default (220)
- Addressing Global Differences in HCC Risk Factors and Management Strategies (2)
- Immune Checkpoint Inhibitors (PD-1/PD-L1) in Hepatocellular Carcinoma Treatment (2)
Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint Inhibition
Lüdemann WM, Kahn J, Herzler P, Collettini F, Savic LJ, Mohr R, Fehrenbach U, Auer TA, Gebauer B, Amthauer H, Wieners G
Journal of Hepatocellular Carcinoma 2025, 12:1-13
Published Date: 3 March 2026
Research Hotspots of Traditional Chinese Medicine for Liver Cancer in the Future Directions: A Bibliometric Analysis
Liu Z, Zhang T, Xue CM, Zhang WT, Zhu BC, Hua GD
Journal of Hepatocellular Carcinoma 2025, 12:3105-3161
Published Date: 31 December 2025
EZH2: From Oncogenic Driver to Therapeutic Target for Overcoming Drug Resistance in Hepatocellular Carcinoma
Tang W, Cao J, Wang N, Tang L, Cao J
Journal of Hepatocellular Carcinoma 2025, 12:3091-3104
Published Date: 31 December 2025
Prognostic Role of Mitotic Index in Hepatocellular Carcinoma: Potential Clinical Implications for Very Early Stage Disease
Choi S, Cho YA, Park S, Koh HH, Park B, Kim K, Yang JD, Ha SY
Journal of Hepatocellular Carcinoma 2025, 12:3077-3090
Published Date: 30 December 2025
Nationwide Prevalence of Hepatocellular Carcinoma in Saudi Arabia: A Population-Based Analysis for 2021
De Vol EB, Bazarbashi S, Aseafan M, Aleid HS, Alnajem A, Alqahtani SA, Alqahtani A
Journal of Hepatocellular Carcinoma 2025, 12:3063-3076
Published Date: 30 December 2025
Combining Transarterial Chemoembolization with Sorafenib Improves Survival in Selected Patients with Hepatocellular Carcinoma and Extrahepatic Spread: A Multicenter Real-World Study
Yuan Y, Qiao Y, Zhu Y, Guo P, Gou J, Liu K, Wang L, Zhao S, Zhang Y, Liu Y, Wang E, Liu L
Journal of Hepatocellular Carcinoma 2025, 12:3049-3062
Published Date: 30 December 2025
CDCA3 Regulates Tumor-Associated Macrophages Polarize to Promote the Malignant Progression of Hepatocellular Carcinoma
Lyu S, Wang E, Lyu J, Xu H, Zhang D, Fang Z, Zhang L
Journal of Hepatocellular Carcinoma 2025, 12:3029-3047
Published Date: 28 December 2025
A Grading System of Intratumoral Tertiary Lymphoid Structure for Combined Hepatocellular-Cholangiocarcinoma: A Multicenter Pathological Study
Wang H, Qian YW, Zhao Y, Sheng X, Xia CY, Chen HZ, Cong WM, He MX, Dong H
Journal of Hepatocellular Carcinoma 2025, 12:3011-3027
Published Date: 25 December 2025
Construction of 3D Enhanced CT Radiomics-Based Model to Predict Circadian Gene Expression and Prognosis in Hepatocellular Carcinoma
Zhao J, Zhou H, Wang C, Zhang W, Pang Y, Zheng H, Zhang L, Zhou J, Hu Z
Journal of Hepatocellular Carcinoma 2025, 12:2989-3009
Published Date: 25 December 2025
Integrated Transcriptomic Analysis Leveraging Single-Cell and Bulk RNA Sequencing Data to Uncover Pyroptosis-Related Prognostic Signatures in HCC
Li J, Di Y, Kang X, Song Z, Sun Z
Journal of Hepatocellular Carcinoma 2025, 12:2971-2988
Published Date: 24 December 2025
TACE-HAIC Plus Targeted Therapy and Immunotherapy for HCC with Tumor Thrombus and Arteriovenous Fistula
Liu X, Yin L, Liu B, Hou X, Li Y, Liu R
Journal of Hepatocellular Carcinoma 2025, 12:2951-2969
Published Date: 24 December 2025
Comparison of the Efficacy and Safety of Transarterial-Chemoembolization versus Radiofrequency-Ablation for Hepatocellular Carcinoma within Milan Criteria: A Propensity Score-Matching Study
Tang W, Huang Y, Wang T, Yang J, Zhao Z
Journal of Hepatocellular Carcinoma 2025, 12:2939-2950
Published Date: 24 December 2025
Prognostic Significance and Mechanistic Insights of Rutin-Related Ferroptosis Gene Signature in Hepatocellular Carcinoma
Yao W, Li H, Zhang Y, Xia X, Wang H, Zhang Z, Shi D
Journal of Hepatocellular Carcinoma 2025, 12:2919-2937
Published Date: 23 December 2025
Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics
Hassan M, Hussain I, Ahmad K, Zafar S, Khalid A, Haseeb M, Hussain N, Ghafar MA
Journal of Hepatocellular Carcinoma 2025, 12:2907-2918
Published Date: 24 December 2025
Prognostic Determinants and Treatment Strategies Associated with Long-Term Survival in Early-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study
Pan KC, Huang HL, Lu SN, Chang TS
Journal of Hepatocellular Carcinoma 2025, 12:2893-2905
Published Date: 23 December 2025
Intra- and Peritumoral Radiomic Signatures on CECT: Prediction of Aggressive Hepatocellular Carcinoma Subtypes and 2-Year Recurrence
Ruan F, Li X, Feng L, Jiang S, Li Z, Long L
Journal of Hepatocellular Carcinoma 2025, 12:2875-2891
Published Date: 21 December 2025
The TBS-PALB-NLR Triad: A Novel Preoperative Prognostic System Guiding Therapeutic Decision-Making in Unresectable HCC Treated with Transarterial Chemoembolization
Yu B, Xu L, Yang W, Yin Y, Yang J, Miao X, Ni C
Journal of Hepatocellular Carcinoma 2025, 12:2859-2873
Published Date: 20 December 2025
Predicting the Occurrence of Cachexia in Patients with BCLC Stage B/C Hepatocellular Carcinoma Receiving Systemic Therapy: A Nomogram Based on Common Clinical Parameters
Ma W, Han J, Yu H, Liang Z, Peng C, Lu Y
Journal of Hepatocellular Carcinoma 2025, 12:2845-2857
Published Date: 20 December 2025
Combined TACE and Microwave Ablation for Recurrent Spiegel-Lobe HCC: A Four-Case Series
Guan X, Hou R, Han Z, Piao X, Zhang S
Journal of Hepatocellular Carcinoma 2025, 12:2839-2844
Published Date: 19 December 2025
Transcatheter Arterial Chemoembolization May Be Selectively Indicated as Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients with Microvascular Invasion
Zeng J, Huang H, Tang M, Tao Z, Mo K, Chen W, Su Y, Su J, Liang R, Lin Y, Li L, Wu G, Luo X, Ye J, Mai R
Journal of Hepatocellular Carcinoma 2025, 12:2825-2838
Published Date: 18 December 2025
The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study
Bayram D, Erdat EC, Özsan Çelebi SN, Türk S, Sekmek S, Perkin P, Aktürk Esen S, Uçar G, Şendur MAN, Uncu D, Köş FT, Civelek B
Journal of Hepatocellular Carcinoma 2025, 12:2811-2823
Published Date: 18 December 2025
Establishment and Significance of a Nomogram Prediction Model for the Risk of Hepatocellular Carcinoma in Budd-Chiari Syndrome
Gao ZK, Wu ZC, Xu H
Journal of Hepatocellular Carcinoma 2025, 12:2795-2809
Published Date: 17 December 2025
BRAP Promotes the Tumorigenesis of Hepatocellular Carcinoma by Corrupting Cancer Cell Cycle Regulation and Enhancing Immune Evasion
Guo Y, Gu R, Gao F, Liu L, Deng D, Zhang Q, Wang L, Liu Q, Lan L, Cang S
Journal of Hepatocellular Carcinoma 2025, 12:2771-2793
Published Date: 16 December 2025
Taurine-Modified Gossypol Exerts Dual Anti-Hepatocellular Carcinoma Effects by Inactivating PI3K/AKT Pathway and Targeting FASN-Mediated Lipid Metabolism in Regulatory T Cells
He W, Shi J, Deng G, Liu W, Kou L, Hu J, Lin Y, Lin X, Sheng J, Wu F
Journal of Hepatocellular Carcinoma 2025, 12:2755-2770
Published Date: 15 December 2025
Liver Resection versus Targeted Therapy Plus PD-1 Inhibitors in Hepatocellular Carcinoma with Type I-II Portal Vein Tumor Thrombus: A Comparative Study
Li L, Li Z, Zhang Y, Zhu S, Ni Y, Xu L, Yan S, Tang Y
Journal of Hepatocellular Carcinoma 2025, 12:2745-2754
Published Date: 16 December 2025
Adjuvant Sintilimab with or without Anti-VEGF Therapy After Resection in Hepatocellular Carcinoma with Microvascular Invasion: A Multicenter Retrospective Study
Wang K, Xiang YJ, Yu HM, Cheng YQ, Zheng YT, Shan YF, Cheng SQ
Journal of Hepatocellular Carcinoma 2025, 12:2735-2744
Published Date: 16 December 2025
Evaluation of Combined Lipiodol and Epirubicin-Loaded Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
Song D, Feng X, Zhou Y, Cai Y, Xue T
Journal of Hepatocellular Carcinoma 2025, 12:2723-2733
Published Date: 12 December 2025
Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma
Eid JR, Yalciner M, Xiao L, Sun R, Kannan MK, Hassan M, Rashid A, Chamseddine S, Tran Cao HS, Amin HM, Kaseb AO
Journal of Hepatocellular Carcinoma 2025, 12:2709-2722
Published Date: 10 December 2025
Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatocellular Carcinoma and Its Correlation with Immune Infiltration
Aimaiti M, Maimaitituxun D, Yilihaer X, Kuerban T, Zhu J, Ainiwaer M, Jia Z, Abudourousuli A
Journal of Hepatocellular Carcinoma 2025, 12:2693-2707
Published Date: 11 December 2025
Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective Study
Luo WL, Wang QB, Li YK, Liang YB, Li J, Chen XM, Lakang Y, Yang ZS, Zuo JX, Wang W, Li SX, Ke Y
Journal of Hepatocellular Carcinoma 2025, 12:2681-2692
Published Date: 5 December 2025
Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma [Corrigendum]
Lu X, Wang Y, Yu Y, Zhang R, Long F, Li M, Pan M, Du K, Tan J, He J, Li Z, Lin H, Li M
Journal of Hepatocellular Carcinoma 2025, 12:2679-2680
Published Date: 5 December 2025
Gastropleural Fistula Following Combined TACE, Immunotherapy, and Bevacizumab in HCC: A Case Report
Xu X, Li J, Pan L, Yu H, Huang J
Journal of Hepatocellular Carcinoma 2025, 12:2671-2677
Published Date: 3 December 2025
Intensity-Modulated Proton Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Liu CM, Lai CH, Wang YM, Huang EY, Chen YH, Ou HY, Hu TH, Hung CH, Lu SN, Chen WY, Huang BS, Cheng JY
Journal of Hepatocellular Carcinoma 2025, 12:2655-2670
Published Date: 1 December 2025
The U-Shaped Association Between Remnant Cholesterol and Postoperative Survival in Hepatocellular Carcinoma: Development and Validation of an Interpretable Machine Learning Model
Liu GM, Liao JP, Xu JW
Journal of Hepatocellular Carcinoma 2025, 12:2639-2653
Published Date: 1 December 2025
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
Lu CH, Chang CW, Chen SC, Kao WY, Ting WY, Lu CH, Chuang KI, Ni CF, Hsieh YY, Wu MS, Su CW, Chang CC, Wu CH
Journal of Hepatocellular Carcinoma 2025, 12:2625-2637
Published Date: 25 November 2025
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study
Kang M, Cha WC, Sinn DH, Jeong WK, Kim DY, Lee MJ, Lim S, Kim D, Kim KP, Ryoo BY, Choi WM, Kim KM, Kim KH, Lee D, Choi EJ, Jung C, Kim J, Hong JY
Journal of Hepatocellular Carcinoma 2025, 12:2611-2623
Published Date: 25 November 2025
Safety and Efficacy of TACE Combined with Lenvatinib and Pembrolizumab in Advanced Hepatocellular Carcinoma (BCLC C): A Retrospective Study
Yang Z, Li J, Jin L
Journal of Hepatocellular Carcinoma 2025, 12:2599-2609
Published Date: 24 November 2025
CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After Hepatectomy
Lei Y, Bai Y, Su Y, Bai X, Wang Y, Zheng C
Journal of Hepatocellular Carcinoma 2025, 12:2585-2598
Published Date: 19 November 2025
Integrative Multi-Omics and Functional Validation Reveal the Role of the TACE Refractoriness-Associated Gene ATP1B3 in Hepatocellular Carcinoma
Zhang C, Hu Q, Meng H, Wu Q, Zeng L, Zheng L, Weng Q, Qiu R, Xu M, Chen M, Chen F, Zhao Z, Yang Y, Ji J
Journal of Hepatocellular Carcinoma 2025, 12:2565-2583
Published Date: 19 November 2025
ARID3A Promotes Tumor Progression by Activating TNF-α/NF-κB Signaling in Dual-Phenotype Hepatocellular Carcinoma
Li M, Yang T, Huang J, Wu X, Chen J, Li J, Shi B, Zhang J, Xiang B
Journal of Hepatocellular Carcinoma 2025, 12:2553-2564
Published Date: 19 November 2025
sCD36 as a Biomarker for Progression and Recurrence in Type 2 Diabetes Mellitus Associated Hepatocellular Carcinoma
Dai W, Yang F, Guo F, Ding Y, He D, Zhang J, Guo Y, Gao Y, Xiao A
Journal of Hepatocellular Carcinoma 2025, 12:2541-2552
Published Date: 14 November 2025
Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents?
Guo H, Chen X, Li R, Shen J, Gan D, Yin Y, Zhang H, Xie J, Xie L, Liu Y
Journal of Hepatocellular Carcinoma 2025, 12:2513-2540
Published Date: 7 November 2025
Risk Factors for Recurrence in Patients with Hepatocellular Carcinoma After Curative Resection or Ablation
Meng F, Wang J, Zhu XD, Zhang M, Zhang X, Cheng D, Zhang X, Liu L
Journal of Hepatocellular Carcinoma 2025, 12:2501-2511
Published Date: 6 November 2025
Low Aggregate Index of Systemic Inflammation Values Correlate with Favorable Prognosis and High Abundance of Parabacteroides in Hepatocellular Carcinoma
Sun W, Zhou F, Shi C, Xu C, Wang Z, Guo X
Journal of Hepatocellular Carcinoma 2025, 12:2491-2500
Published Date: 6 November 2025
ANT Score Nomogram for Predicting Very Early Recurrence of Hepatocellular Carcinoma
Yu Z, Wang H, Huo Q, Cao W, Jin L, Liu J, Wei F
Journal of Hepatocellular Carcinoma 2025, 12:2477-2490
Published Date: 5 November 2025
Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic Model
Hao A, Li C, Sun R, Tan B, Shao G, Li K, Li N, Hu W, Qu C, Cao J
Journal of Hepatocellular Carcinoma 2025, 12:2459-2475
Published Date: 1 November 2025
The Role of Nuclear Medicine in Predicting Treatment Response to Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma: A Narrative Review
Tu H, Lin D, Chen C
Journal of Hepatocellular Carcinoma 2025, 12:2445-2457
Published Date: 31 October 2025
Cms1 Ribosomal Small Subunit Homolog Promotes HCC Proliferation and Migration by Modulating the TNF/NF-κB Signaling Pathway
Zhang T, Huang Y, Hu S, Yu Y, Qin F, Zhang Y, Cai Z, Wang H, Zhang P, Dai J
Journal of Hepatocellular Carcinoma 2025, 12:2429-2443
Published Date: 28 October 2025
Spontaneous Rupture of Hepatocellular Carcinoma: Pathogenesis, Clinical Management, Prognostic Factors, and Future Directions
Cheng Y, Ye F, Chen Y
Journal of Hepatocellular Carcinoma 2025, 12:2421-2428
Published Date: 27 October 2025
Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma
Mai RY, Tao Z, Huang HY, Zeng C, Mo KX, Zeng DD, Liang R, Lin Y, Wang XB, Bai T, Li LQ, Ye JZ, Wu GB
Journal of Hepatocellular Carcinoma 2025, 12:2407-2419
Published Date: 27 October 2025
The Long Non-Coding RNA SNHG16 Negatively Regulates Let-7 and Predicts Recurrence in Hepatocellular Carcinoma
Shi W, Dong J, Li H, Jing L, Guo H, Liu T, Li C, Gao Y
Journal of Hepatocellular Carcinoma 2025, 12:2393-2406
Published Date: 23 October 2025
Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study
Chen X, Xing J, Zhang B, Peng W, Huang Z, Zhu T, Liu L, Liu X, Wan X, Mao Y, Chang X, Zhou K, Pan J, Hu D, Tan H, Zhang Y, Guan M, Du S
Journal of Hepatocellular Carcinoma 2025, 12:2379-2391
Published Date: 21 October 2025
P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACE
Attia A, Elshimi EA, Seif Eldin ZM, Rady MAM, Alkhatib A, Gomaa AI, Fouad TR, Waked I
Journal of Hepatocellular Carcinoma 2025, 12:2369-2378
Published Date: 21 October 2025
Prognostic Signature of NETs-Related Genes in Hepatocellular Carcinoma Based on Bulk and Single-Cell Transcriptomics
Lu N, Gu Z, Yuan X, Jin R, Li J
Journal of Hepatocellular Carcinoma 2025, 12:2351-2367
Published Date: 15 October 2025
Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
Chen CT, Chuang CH, Hsu CH, Shao YY
Journal of Hepatocellular Carcinoma 2025, 12:2341-2349
Published Date: 15 October 2025
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication
Hsu WF, Lo CC, Tseng KC, Lai HC, Chen CY, Peng CY
Journal of Hepatocellular Carcinoma 2025, 12:2327-2339
Published Date: 13 October 2025
Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
Lu X, Wang Y, Yu Y, Zhang R, Long F, Li M, Pan M, Du K, Tan J, He J, Li Z, Lin H, Li M
Journal of Hepatocellular Carcinoma 2025, 12:2307-2325
Published Date: 13 October 2025
Impact of Cytokeratin 19 Expression on the Outcomes of Unresectable Hepatocellular Carcinoma Treated with Targeted Therapy and Immunotherapy: A Propensity Score Matched Analysis
Liu J, Yuan T, Lv X, Tan G, Xue L, Huang Z
Journal of Hepatocellular Carcinoma 2025, 12:2295-2305
Published Date: 10 October 2025
Prognostic Value of Clinical and CT Features in Camrelizumab Plus Apatinib Treatment for Unresectable Hepatocellular Carcinoma
Che J, Chen Y, Zeng Z, Li C, Zhang L, Huang X, Huang F, Wang Y, Huang W, Song B, Long L
Journal of Hepatocellular Carcinoma 2025, 12:2279-2293
Published Date: 9 October 2025
Establishing a Survival Time Prediction Model for Patients with Hepatocellular Carcinoma After TACE Based on CT Radiomics: A Multi-Center Study
Yang H, Zhao J, Wang Y, Zhu D, Gu J, Ren W
Journal of Hepatocellular Carcinoma 2025, 12:2263-2277
Published Date: 7 October 2025
MRI-Based Deep Learning and Radiomics Nomogram for Predicting Hepatocellular Carcinoma Recurrence Within Six Months After Thermal Ablation
Chen Y, Zhao Y, Guan W, Wu D, Zheng L, Chen C, Geng X, Qi H, Song HY, Hu H
Journal of Hepatocellular Carcinoma 2025, 12:2247-2261
Published Date: 6 October 2025
Early PIVKA-II Response Associated with Treatment Efficacy and Survival Outcomes for Patients with Advanced Hepatocellular Carcinoma Receiving Immune Checkpoint Inhibitors and Targeted Therapy
Fang ZK, Xiao YT, Feng X, Shi ZJ, Liu SY, Yu Y, Jin LM, Huang DS, Zhang CW, Liu JW, Liang L
Journal of Hepatocellular Carcinoma 2025, 12:2235-2246
Published Date: 2 October 2025
The Prognostic Value of Lymphocyte-to-Monocyte Ratio for Long-Term Survival After TACE in Intermediate-to-Advanced Hepatocellular Carcinoma
Du J, Yang W, Liu R, Xie P
Journal of Hepatocellular Carcinoma 2025, 12:2225-2233
Published Date: 2 October 2025
Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study
Leng Z, Zhu T, Huang Z, Chen X, Lu Y, Zhang Y, Wan X, Yang X, Zhang L, Zhao H, Du S, Zhao Z, Zheng Y
Journal of Hepatocellular Carcinoma 2025, 12:2213-2224
Published Date: 30 September 2025
An Interpretable Radiomics-Based Model Using Susceptibility-Weighted Imaging for Non-Invasive Prediction of Tertiary Lymphoid Structures in Hepatocellular Carcinoma
Liu L, Gao F, Li Y, Cheng J, Zhang H, Cai P, Chen W, Li X
Journal of Hepatocellular Carcinoma 2025, 12:2197-2211
Published Date: 30 September 2025
CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma
Ren L, Chen D, Xu T, Wei R, Zhao B, Zhou Y, He Y, Liao M, Chen H, Liao W
Journal of Hepatocellular Carcinoma 2025, 12:2183-2196
Published Date: 29 September 2025
A Refined Prognostic Model for Postoperative Overall Survival in Hepatocellular Carcinoma Based on CODEX-Based Multiproteomics and Radiomics
Wu Y, Wu J, Duan S, Liu D, Liu W, Song K, Zhang J, Feng Y, Zhang S, Liu Y, Dong H, Zhang H, Chen L, Jia N
Journal of Hepatocellular Carcinoma 2025, 12:2169-2182
Published Date: 26 September 2025
Low Indoleamine 2,3-Dioxygenase 1 Expression Enhances Dendritic Cells Response to Tumor Cells Against Hepatocellular Carcinoma
Mo C, Hong M, Li Y, Huang D, Ji Q, Liu Y
Journal of Hepatocellular Carcinoma 2025, 12:2149-2167
Published Date: 20 September 2025
A Retrospective Evaluation of Setup Errors Associated with Respiratory Motion Management Techniques in Stereotactic Body Radiation Therapy for Hepatic Malignancies
Han JH, He DC, Zhang XY, Zhang Y, Hong J, Shi TT, Zhu ZJ
Journal of Hepatocellular Carcinoma 2025, 12:2139-2147
Published Date: 20 September 2025
A Multicenter Retrospective Study: Impact of First-Line Treatment Strategies on second-Line Efficacy and Safety of Regorafenib with or Without PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma
Ma W, Li Y, Lu Y, Liang Z, Yu H, Han J, Liu J, Wang W, Peng C, Cheng J
Journal of Hepatocellular Carcinoma 2025, 12:2123-2137
Published Date: 16 September 2025
Methodological Quality of Systematic Reviews on Treatments for Liver Cancer: A Cross-sectional Study
Cheng BZZ, Wang BH, Zhong CC, Zhang Y, Ho FF, Chung VC
Journal of Hepatocellular Carcinoma 2025, 12:2109-2121
Published Date: 16 September 2025
CT-Based 2.5D Deep Learning-Multi-Instance Learning for Predicting Early Recurrence of Hepatocellular Carcinoma and Correlating with Recurrence-Related Pathological Indicators
Cen Y, Nong H, Du D, Wu Y, Chen J, Pan Z, Huang Y, Ding K, Huang D
Journal of Hepatocellular Carcinoma 2025, 12:2095-2108
Published Date: 17 September 2025
TACE-HAIC versus TACE as Initial Regional Therapy for Unresectable Huge Hepatocellular Carcinoma (>10 cm): A Propensity Score-Matched Study
Liu C, Li J, Zhao M, Zheng L, Xiao JC
Journal of Hepatocellular Carcinoma 2025, 12:2083-2093
Published Date: 15 September 2025
CT-Based Radiomics Features Combined with AFP for Predicting Vessels Encapsulating Tumor Clusters and Prognosis of Hepatocellular Carcinoma
Wei Y, Huang S, Huang L, Pei W, Zuo Y, Liao H
Journal of Hepatocellular Carcinoma 2025, 12:2069-2081
Published Date: 13 September 2025
Tumor Compression of the Hepatic or Portal Vein Predicts the Presence of Microvascular Invasion and Satellite Nodules in Hepatocellular Carcinoma: A Retrospective Study
Wang QB, Luo WL, Li YK, Li J, Yang ZS, Zhao K, Lakang Y, Liang YB, Chen XM, Zuo JX, Duan Y, Xu X, Shang LM, Ke Y
Journal of Hepatocellular Carcinoma 2025, 12:2055-2067
Published Date: 12 September 2025
Radiation-Induced Liver Injury: An Overview
Sun J, Lu HR, Wu JH, Li D, Zhang T, Duan XZ
Journal of Hepatocellular Carcinoma 2025, 12:2045-2054
Published Date: 10 September 2025
Prognostic Significance of Liquid Biopsy-Detected Genetic Alterations in Hepatocellular Carcinoma
Sarıtaş AG, Yavuz B, Aydın İ, Ağca H, Topal U, Ballı T, Bisgin A, Ülkü A, Akçam AT
Journal of Hepatocellular Carcinoma 2025, 12:2035-2043
Published Date: 5 September 2025
Newly Established Anoikis-Associated Genes Predict the Prognosis of Hepatocellular Carcinoma
Li Y, Li E, Zheng W, Shi J, Yu S, Zhang X, Zheng L, Du W, Liu H, Feng H, Guo J, Yu Z
Journal of Hepatocellular Carcinoma 2025, 12:2017-2034
Published Date: 3 September 2025
Efficacy and Safety of Different Doses of Bevacizumab Combined with Atezolizumab in Unresectable Hepatocellular Carcinoma
Zhang S, Wang J, Zhu Z, Ji P, Wang Y, Cheng K, Nashan B, Liu L, Zhang S
Journal of Hepatocellular Carcinoma 2025, 12:2007-2015
Published Date: 31 August 2025
Primary Prophylaxis for High-Risk Varices in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus Delayed Hepatic Decompensation: A Retrospective, Propensity Score Matching Study [Corrigendum]
Chen YJ, Hou MC, Yang TC, Lee PC, Lu HS, Huang HC, Huang YH, Luo JC
Journal of Hepatocellular Carcinoma 2025, 12:2005-2006
Published Date: 30 August 2025
Prognostic Role of Short-Chain Fatty Acid-Producing Gut Microbiota and Gut Microbial Dynamics in Patients with Hepatocellular Carcinoma Receiving Chemoembolization: A Prospective Study
Yang J, Lim J, Kim EH, An J, Lee D, Lee HC, Jeong JY, Shim JH
Journal of Hepatocellular Carcinoma 2025, 12:1991-2004
Published Date: 31 August 2025
Exploration of the Mechanism of Action of Dendrobium officinale in the Treatment of Liver Cancer Based on Network Pharmacology, Molecular Docking and in vitro Validation
Zhan S, Lu X, Guo H, Liu Y, Li Z, Xu W, Xia F, Tang H, Tian Y, Chen J, Lin X
Journal of Hepatocellular Carcinoma 2025, 12:1973-1990
Published Date: 28 August 2025
Multiparametric MRI–Based Machine Learning Radiomics Prognostic Models for Multifocal Hepatocellular Carcinoma Beyond Milan Criteria: A Retrospective Study
Liang X, Wu F, Zheng X, Xiao Y, Yang C, Zeng M
Journal of Hepatocellular Carcinoma 2025, 12:1957-1972
Published Date: 28 August 2025
Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Sintilimab Plus Bevacizumab Biosimilar in the Treatment of Unresectable Hepatocellular Carcinoma
Qin H, Jiang K, Liu C, Lin H, Xia J, Ya H, Gu J, Suo L, Li B, Deng X, Wang D, Huang X, Li S
Journal of Hepatocellular Carcinoma 2025, 12:1943-1955
Published Date: 27 August 2025
Screening Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Patients After Tyrosine Kinase Inhibitor Plus PD-1/PD-L1 Antibody Therapy: A Multicenter Retrospective Study
Jin Z, Li X, Lv L, Zhang B, Ma X, Chen S, You J, Wu X, Wang L, Liu X, Wang F, Chen X, Yu L, Zhang S, Zhang L
Journal of Hepatocellular Carcinoma 2025, 12:1921-1941
Published Date: 25 August 2025
Triple Therapy with Interventional Treatment, Donafenib, and Anti-PD-1 Antibodies in Unresectable Hepatocellular Carcinoma: A Retrospective Real-World Study in China
Ye Q, Song Z, Yu T, Li Y, Ai L, Yang G, Su K, Chen D, Zhao W, Ding R, Zha Y, Li G
Journal of Hepatocellular Carcinoma 2025, 12:1905-1919
Published Date: 24 August 2025
The Predictive Significance of Interleukin-2 Receptor in Patients with Hepatocellular Carcinoma
Tian Z, Guo Y, Yang R, Yang W
Journal of Hepatocellular Carcinoma 2025, 12:1893-1904
Published Date: 22 August 2025
ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma
Ding J, Zou X, Huang X, Yu L, Hong H, Lin T
Journal of Hepatocellular Carcinoma 2025, 12:1873-1892
Published Date: 21 August 2025
A Comparative Study of Five Large Language Models’ Response for Liver Cancer Comprehensive Treatment
Zhong D, Liang Y, Yan HT, Chen X, Yang Q, Ma S, Su Y, Chen Y, Huang X, Wang M
Journal of Hepatocellular Carcinoma 2025, 12:1861-1871
Published Date: 20 August 2025
A Patient Charter to Improve Care for Hepatocellular Carcinoma
Hassan Y, Kautz A, James C, Lee D, Langenbacher D, Bouffet E, Chakowa J, Hicks J, Ward JW, Kuschnereit LA, Allaire M, Zhang T, Huang Chi Z
Journal of Hepatocellular Carcinoma 2025, 12:1849-1859
Published Date: 20 August 2025
A Clinical-Imaging Nomogram for Predicting Early Recurrence in Patients with Solitary Hepatocellular Carcinoma After Postoperative Adjuvant TACE
Liu J, Ding X, Zhang Y, Li H
Journal of Hepatocellular Carcinoma 2025, 12:1835-1847
Published Date: 19 August 2025
Efficacy and Safety of the Multi-Level Comprehensive Collateral Artery Embolism Sequential Hepatic Arterial Infusion Chemotherapy, Combined with TKI and ICI, for Unresectable Huge Hepatocellular Carcinoma (>10cm): A Propensity Score Matching Cohort Study
Tan HY, Liu SQ, Liu YH, Zheng JL, Feng HG
Journal of Hepatocellular Carcinoma 2025, 12:1821-1834
Published Date: 19 August 2025
A Novel Quadruple Conversion Therapy: Converting Initially Unresectable Hepatocellular Carcinoma to Resectable with pTAE-HAIC, Tyrosine Kinase Inhibitors, and Anti-PD-1 Antibodies
Xiao J, Li Q, Zheng W, Liao K, Yu Q, Huang R, Zhou R
Journal of Hepatocellular Carcinoma 2025, 12:1807-1819
Published Date: 14 August 2025
TACE Sequential to Radiofrequency Ablation versus RFA Alone in Hepatocellular Carcinoma Within Milan Criteria
Yan H, Zhao C, Liu M, Liu H, Mu L, Xiang Z, Huang M
Journal of Hepatocellular Carcinoma 2025, 12:1795-1805
Published Date: 12 August 2025
Transarterial Chemoembolization Following Curative Resection May Not Improve Survival for Hepatitis B Virus Associated Intrahepatic Cholangiocarcinoma: Propensity Score Weighting Analysis
Liu G, Liu W, Zhou F, Qiu J, Yang X, Kou X, Guo L, Ding Y, Liu H, Zhou H
Journal of Hepatocellular Carcinoma 2025, 12:1781-1793
Published Date: 12 August 2025
Whether Adjuvant TACE Plus TKI Therapy is More Effective Than TACE Alone in HCC Patients at High Risks of Recurrence Following Radical Hepatectomy
Li Y, Wang K, Qin H, Huo S, Jiang K, Xia J, Gu J, Ya H, Suo L, Wang D, Huang X, Li S
Journal of Hepatocellular Carcinoma 2025, 12:1767-1780
Published Date: 11 August 2025
Predictive Radiomics-Based Model for Recurrence-Free Survival After Curative Resection in Patients with Hepatocellular Carcinoma
Cui J, Lin Z, Huang X, Wang S, Guo J, Song J, Zhang S, Lv J, Qiu W
Journal of Hepatocellular Carcinoma 2025, 12:1755-1766
Published Date: 7 August 2025
Predictive Value of IDEAL-IQ and DWI Imaging Biomarkers for P53 Mutations in Hepatocellular Carcinoma
Wang D, Yin H, Li X, Zhou S, Wang YC
Journal of Hepatocellular Carcinoma 2025, 12:1743-1753
Published Date: 6 August 2025
Triphasic CT Radiomics Model for Preoperative Prediction of Hepatocellular Carcinoma Pathological Grading
Huang H, Pan X, Zhang Y, Yang J, Chen L, Zhao Q, Huang L, Lu W, Deng Y, Huang Y, Ding K
Journal of Hepatocellular Carcinoma 2025, 12:1725-1742
Published Date: 6 August 2025
Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular Carcinoma
Liu S, Xie Y, Li T, Huang Y, Xu D, Cai L, Fu Y, Chen J, Zhang Y, Huang J, Hu Z
Journal of Hepatocellular Carcinoma 2025, 12:1711-1723
Published Date: 5 August 2025
GALNT14 Genetic Variants Harbor Differential Prognostic Values Linking to Distinct Macrophage Cell Types in Hepatocellular Carcinoma
Chu YD, Ho PH, Chen WT, Shih YL, Lai MW, Hsu CW, Yeh CT
Journal of Hepatocellular Carcinoma 2025, 12:1695-1710
Published Date: 4 August 2025
Beta-Catenin Mutations Can Impact on the Interplay Between Tumor and Immune Cells and Hepatic Microbiota in Hepatocellular Cancer
Ota Y, Driscoll J, Hill AR, Yan IK, Patel T
Journal of Hepatocellular Carcinoma 2025, 12:1677-1693
Published Date: 1 August 2025
Single-Cell RNA Sequencing Integrated with Bulk-RNA Sequencing Analysis Reveals Prognostic Signatures Based on PANoptosis in Hepatocellular Carcinoma
Wang J, Yin X, Li Z, Liang P, Wang Y, Li X, Qiao W, Xiong C, Yu M, Ding X, Wang X
Journal of Hepatocellular Carcinoma 2025, 12:1661-1676
Published Date: 29 July 2025
A CT-Based Deep Learning Radiomics Scoring System for Predicting the Prognosis to Repeat TACE in Patients with Hepatocellular Carcinoma: A Multicenter Cohort Study
Dai Y, Zhao S, Wu Q, Zhang J, Zeng X, Jiang H
Journal of Hepatocellular Carcinoma 2025, 12:1647-1659
Published Date: 29 July 2025
Distinct Roles of HHLA2 and PD-L1 in the Immune Cell and Prognosis of Hepatocellular Carcinoma
Wang CH, Chen SL, Yang X, Wu T, Liu LL, Yun JP
Journal of Hepatocellular Carcinoma 2025, 12:1633-1645
Published Date: 25 July 2025
Survival Outcomes and Prognostic Factors of Systemic Therapy for Advanced Hepatocellular Carcinoma: A Multidisciplinary Clinic Experience from Saudi Arabia
Asiri M, BinAbdu A, Al-Ammar A, Alsuaib AA, Al-Shehri A, Almazyad AA, Aloufi AM, AlGazlan N, Alrajih HS, Alkaiyat M, Ardah HI, Shehata H, Alshammari K
Journal of Hepatocellular Carcinoma 2025, 12:1623-1632
Published Date: 23 July 2025
Natural Bioactive Compounds Targeting the Wnt/β-Catenin Pathway for the Treatment of Hepatocellular Carcinoma
Tian H, Wang P, Shao H
Journal of Hepatocellular Carcinoma 2025, 12:1613-1622
Published Date: 23 July 2025
Automatic Real-Time Detection and Diagnosis of Liver Tumor with Ultrasound
Wu CH, Sheu JC, Chou PL, Lee J, Nien HC
Journal of Hepatocellular Carcinoma 2025, 12:1599-1611
Published Date: 23 July 2025
Comparison of Long-Term Outcomes Between Repeated Hepatic Resection and Radiofrequency Ablation in Patients with Small Recurrent Hepatocellular Carcinoma After Initial Curative Resection: A Propensity Score Matched Study
Hsiao CY, Hu RH, Liang PC, Wu CH
Journal of Hepatocellular Carcinoma 2025, 12:1587-1598
Published Date: 23 July 2025
Exploring Autophagy-Related Gene Expression in Hepatocellular Carcinoma via TCGA, GEPIA2, and HPA Databases: Implications for Prognosis
Gu X, Chen Y, Hu X, Li Y, Zhu R, Li H, Yuan Z, Wang Y
Journal of Hepatocellular Carcinoma 2025, 12:1557-1586
Published Date: 22 July 2025
FAM105B Promotes Hepatocellular Carcinoma Progression and Metastasis by Activating the PI3K/AKT/MTOR Signaling Pathway and Inducing Epithelial-Mesenchymal Transition
Yang LL, Chen X, Tang ST, Huang KT, Ye GY, Wang JL
Journal of Hepatocellular Carcinoma 2025, 12:1541-1555
Published Date: 22 July 2025
TACE Combined with Lenvatinib-PD-1 Versus TACE Monotherapy as Conversion Therapy Before Liver Resection in Unresectable Hepatocellular Carcinoma: A Retrospective, Propensity Score Matching Study
Lu C, Liu R, Zhang Y, Luo J, Luo C, Jiang Z, Huang M, Qiu C, Chen J
Journal of Hepatocellular Carcinoma 2025, 12:1527-1540
Published Date: 22 July 2025
AI-Based Quantification of Enhancing Tumor Volume on Contrast-Enhanced MRI to Predict Pathologic Response and Prognosis in HCC After HAIC Plus Targeted Therapy and Immunotherapy
Zhou Y, Li J, Li Q, Liu L, Huang P, Mao Y, Yang Y, Lv F, Liu Z
Journal of Hepatocellular Carcinoma 2025, 12:1509-1525
Published Date: 21 July 2025
Survival Benefit of Adjuvant Treatment with Huaier Granules Plus Lenvatinib in Hepatocellular Carcinoma Patients with Tumors Greater Than 5 cm After Radical Hepatectomy
Liu C, Bai Y, Bai Q, Parra MA, Zhao L, Zou J, Cao Q, Liu H, Yang H
Journal of Hepatocellular Carcinoma 2025, 12:1495-1507
Published Date: 20 July 2025
Functional Liver Imaging Score to Predict Clinically Significant PHLF for Hepatocellular Carcinoma After Resection
Zheng X, Zhang Y, Huang H, Luo N
Journal of Hepatocellular Carcinoma 2025, 12:1483-1493
Published Date: 18 July 2025
Prognostic Value of Gd-BOPTA Enhanced MRI in Solitary Resected Hepatocellular Carcinoma Without Microvascular Invasion
Zhang J, Luo H, Li Y, Feng Y, Pan X, Ouyang B, Nian G, Jia N, Li Y
Journal of Hepatocellular Carcinoma 2025, 12:1471-1482
Published Date: 18 July 2025
Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma
Zhang J, Xu Y, Ni X, Mao Z, Xiao H, Chen M, Lin Y, Pan J, Zhang B, Zhang L, Zheng X, Song G, Ge N
Journal of Hepatocellular Carcinoma 2025, 12:1453-1469
Published Date: 17 July 2025
Can Peritumoral Radiomics Based on MRI Predict the Microvascular Invasion Status of Combined Hepatocellular Carcinoma and Cholangiocarcinoma Before Surgery?
Guo L, Huang C, Hao P, Jia N, Zhang L
Journal of Hepatocellular Carcinoma 2025, 12:1441-1452
Published Date: 16 July 2025
Adjuvant Hepatic Arterial Infusion Chemotherapy Versus Transarterial Chemoembolization for Preventing Early Recurrence After Surgical Resection in Hepatocellular Carcinoma
Xia Y, Wen W, Liao Y, Cai Y, Wan R
Journal of Hepatocellular Carcinoma 2025, 12:1425-1439
Published Date: 16 July 2025
A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030
Lau-Min KS, Abrams T, Bullock A, Kaplan A, Salas Karnes L, Kennedy MW, LeBedis CA, Lin MV, McCleary NJ, Sioshansi S, Voligny E, Walsh EP, Manz CR
Journal of Hepatocellular Carcinoma 2025, 12:1417-1424
Published Date: 16 July 2025
Efficacy Analysis of TACE Combined with Lenvatinib and PD-1 Inhibitors in the Treatment of Hepatitis B Virus-Related Unresectable Hepatocellular Carcinoma
Yu J, Zhu Y, Zhao S, Li X
Journal of Hepatocellular Carcinoma 2025, 12:1407-1415
Published Date: 15 July 2025
Refining Intra-Arterial Therapy Selection for Large Hepatocellular Carcinoma: A Deep Learning Approach Based on Covariate Interaction Analysis
An C, Li L, Luo Y, Zuo M, Liu W, Li C, Wu P
Journal of Hepatocellular Carcinoma 2025, 12:1393-1405
Published Date: 11 July 2025
Silencing NEDD4L Effectively Inhibits the Malignant Behaviors of Hepatocellular Carcinoma
Dai J, Zhu T, Wan J, Liu R, Song Y, Zhang D, Wang X, Zhang H, Li W, Lin J, Zhu X, Liu Y
Journal of Hepatocellular Carcinoma 2025, 12:1369-1391
Published Date: 10 July 2025
Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Donafenib and Camrelizumab in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Retrospective, Single-Arm Study
Wu C, Fu Z, Pan L, Li J, Zhou Y, Sun R, Gou Y, Zhao Y, Wang Z, Qiu Y, Huang P
Journal of Hepatocellular Carcinoma 2025, 12:1353-1367
Published Date: 10 July 2025
Hsa_circ_0007991 Promotes Immune Evasion in Hepatocellular Carcinoma via Regulation of the miR-505-3p/CANX Axis
Wang L, Liang L, Qian J, Yu C, Shi Y, Yan X, Chen X
Journal of Hepatocellular Carcinoma 2025, 12:1337-1351
Published Date: 7 July 2025
Multidisciplinary Team Management of Hepatocellular Carcinoma in the MENA Region: Current Practices, Challenges, and Gaps
El-Kassas M, Khalifa R, AlNaamani KM, Shousha H, Yilmaz Y, Sanai FM, Almattooq M, Labidi A, Akroush MWI, Debzi N, Abdelmalek MO, Abdeen NS, Tumi A, Elbadry M, El Fouly A, Marwan E, Al Suwaidi J, Elzouki AN, Alswat KA
Journal of Hepatocellular Carcinoma 2025, 12:1315-1335
Published Date: 8 July 2025
Hyper-Relapse Disease is a Special Pattern of Relapse of Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study
Yang ZL, Gan YX, Xu JX, Tang YH, Ouyang LY, Qi LN, Xu L
Journal of Hepatocellular Carcinoma 2025, 12:1301-1314
Published Date: 5 July 2025
Integrating CEUS Imaging Features and LI-RADS Classification for Postoperative Early Recurrence Prediction in Solitary Hepatocellular Carcinoma: A Machine Learning-Based Prognostic Approach
Liang L, Pang J, Zhang B, Que Q, Gao R, Wu Y, Peng J, Zhang W, Bai X, Wen R, He Y, Yang H
Journal of Hepatocellular Carcinoma 2025, 12:1287-1300
Published Date: 3 July 2025
Retrospective Multicentre Real-Life Study Evaluating the Efficacy of Atezolizumab Combined with Bevacizumab for the Treatment of Metastatic Hepatocellular Carcinoma: HIREAL Study
Barbe-Richaud JB, Moinard-Butot F, Husson-Wetzel S, Bolliet M, Chiappa P, Belletier C, Ribeiro M, Poprawa E, Bigot C, Abergel A, Ben Abdelghani M
Journal of Hepatocellular Carcinoma 2025, 12:1279-1286
Published Date: 1 July 2025
Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study
Shen X, Shao T, Yu J, Zhang Z
Journal of Hepatocellular Carcinoma 2025, 12:1267-1278
Published Date: 2 July 2025
Preoperative Prediction of a Rare and Highly Aggressive Subtype of Hepatocellular Carcinoma Based on Multimodal Imaging and Clinical Indicators
Chen K, Zhu Y, Liu H, Deng M, Kong W, Wang W
Journal of Hepatocellular Carcinoma 2025, 12:1253-1266
Published Date: 30 June 2025
Clinical Outcomes of AFP-Negative Patients with Advanced HCC: A Propensity-Matched Analysis from a Retrospective Cohort Study
Liu X, Zhuang L, Yang F, Liu P, Xia Z, Guo Y, Dong P, Chen C, Li Z
Journal of Hepatocellular Carcinoma 2025, 12:1241-1252
Published Date: 27 June 2025
Comparison of Computed Tomography and Ultrasound-Guided Radiofrequency Ablation for Recurrent Subdiaphragmatic Hepatocellular Carcinoma After Resection
Liu HY, Hsiao CY, Hu RH, Liang PC, Wu CH
Journal of Hepatocellular Carcinoma 2025, 12:1231-1240
Published Date: 27 June 2025
Treatment Outcomes of Systemic Therapies for Infiltrative Hepatocellular Carcinoma
Chen PY, Chang CK, Chen BB, Hsu CH, Cheng AL, Shao YY
Journal of Hepatocellular Carcinoma 2025, 12:1221-1229
Published Date: 23 June 2025
Application of Robotic Surgery in Hepatocellular Carcinoma
Li PH, Ding ZW, Ye YQ
Journal of Hepatocellular Carcinoma 2025, 12:1217-1220
Published Date: 19 June 2025
Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy
Zheng X, Qian K
Journal of Hepatocellular Carcinoma 2025, 12:1205-1215
Published Date: 17 June 2025
In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma
Liang JD, Liang PC, Shun CT, Chen CH, Wu YM, Hsu YC, Lee YT, Yang PM, Huang GT, Salazar AM, Lee HS, Sheu JC, Weng MT
Journal of Hepatocellular Carcinoma 2025, 12:1191-1204
Published Date: 14 June 2025
Intravoxel Incoherent Motion Improves the Accuracy of Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma
Li M, Zhang G, Li J, Ren Y, Jin X, Ke Q, Guo C, Lv J, Lu H, Xu Y, Liang W, Quan X, Li X
Journal of Hepatocellular Carcinoma 2025, 12:1177-1190
Published Date: 11 June 2025
Early Recurrence of Hepatocellular Carcinoma in Patients without Microscopic Vascular Invasion: Clinicopathological Characteristics and Risk Factors
Ngo HTT, Nguyen DD, Dang MX, Doan TTP, Thai TT
Journal of Hepatocellular Carcinoma 2025, 12:1167-1175
Published Date: 11 June 2025
Genetic Variants of UGP2 and FBP2 in the Glycolysis Pathway Independently Predict Survival of Patients with HBV-Related Hepatocellular Carcinoma
Gong R, Qiu M, Liu Y, Cao J, Zhou Z, Lin Q, Jiang Y, Liang X, Wei Y, Wen Q, Chen P, Wei X, Wei J, Zhan S, Zhang R, Ye D, Yu H
Journal of Hepatocellular Carcinoma 2025, 12:1155-1166
Published Date: 7 June 2025
Factor Analysis of the Effect of Hepatitis B-Related Liver Cancer Treatment Efficacy
Liu SW, Zhou Y, Feng XY, Hai L, Ma WL, Ma LN, Ding XC, Luo X
Journal of Hepatocellular Carcinoma 2025, 12:1141-1154
Published Date: 5 June 2025
Radiomics and Deep Learning as Important Techniques of Artificial Intelligence — Diagnosing Perspectives in Cytokeratin 19 Positive Hepatocellular Carcinoma
Wang F, Yan C, Huang X, He J, Yang M, Xian D
Journal of Hepatocellular Carcinoma 2025, 12:1129-1140
Published Date: 5 June 2025
Predicting Resistance and Survival of HCC Patients Post-HAIC: Based on Shapley Additive exPlanations and Machine Learning
Yao F, Miao J, Quan B, Li J, Tang B, Lu S, Yin X
Journal of Hepatocellular Carcinoma 2025, 12:1111-1128
Published Date: 31 May 2025
Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma
Song Z, Zheng X, Wang H, Dong D, Zhu X, Geng J, Li S, Song M, Du R, Zhang Y, Liu Z, Cai Y, Li Y, Wang W
Journal of Hepatocellular Carcinoma 2025, 12:1097-1110
Published Date: 31 May 2025
Intratumoral and Peritumoral Radiomics Based on DCE-MRI for Prediction of Microvascular Invasion Grading in Solitary Hepatocellular Carcinoma (≤3 cm)
Li Y, Li H, Feng Y, Lu L, Zhang J, Jia N
Journal of Hepatocellular Carcinoma 2025, 12:1083-1095
Published Date: 30 May 2025
Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors: A Retrospective Analysis
Fu X, Jiang S, Li Y, Guo Y, Gong B, Lou J, Li Y, Wang S, Sun Y, Ren Y, Chen Q, Yang L
Journal of Hepatocellular Carcinoma 2025, 12:1069-1082
Published Date: 30 May 2025
Primary Prophylaxis for High-Risk Varices in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus Delayed Hepatic Decompensation: A Retrospective, Propensity Score Matching Study
Chen YJ, Hou MC, Yang TC, Lee PC, Lu HS, Huang HC, Huang YH, Luo JC
Journal of Hepatocellular Carcinoma 2025, 12:1057-1067
Published Date: 28 May 2025
Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study
Sun HC, Huang ZY, Wen T, Liu L, Zhu XD, Zhang E, Li C, Zhang X, Wang J, Fan J, Zhou J
Journal of Hepatocellular Carcinoma 2025, 12:1043-1056
Published Date: 22 May 2025
Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study
Lu J, Chen X, Liu Y, Ding Y, Li B, Yang J, Peng W, Yang X
Journal of Hepatocellular Carcinoma 2025, 12:1031-1041
Published Date: 23 May 2025
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients
Liu CW, Lin PT, Teng W, Chen WT, Su CW, Hsieh YC, Lin CC, Lin CY, Lin SM
Journal of Hepatocellular Carcinoma 2025, 12:1017-1029
Published Date: 21 May 2025
Radiomics of Dynamic Contrast-Enhanced MRI for Predicting Radiation-Induced Hepatic Toxicity After Intensity Modulated Radiotherapy for Hepatocellular Carcinoma: A Machine Learning Predictive Model Based on the SHAP Methodology
Liu F, Chen L, Wu Q, Li L, Li J, Su T, Li J, Liang S, Qing L
Journal of Hepatocellular Carcinoma 2025, 12:999-1015
Published Date: 17 May 2025
MRI Radiomics to Predict Early Treatment Response to TACE Combined with Lenvatinib Plus a PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Lu D, Zhou L, Zuo Z, Zhang Z, Zheng X, Weng J, Yu Z, Ji J, Xia J
Journal of Hepatocellular Carcinoma 2025, 12:985-998
Published Date: 16 May 2025
Atezolizumab Plus Bevacizumab Combined with or without Transarterial Chemoembolization in the Treatment of Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Study
Li J, Bai Y, Xiong F, Liu X, Hu J, Zhang G, Liu J, Wu S, Zheng C, Kan X
Journal of Hepatocellular Carcinoma 2025, 12:973-984
Published Date: 15 May 2025
The Real-World Prevalence of Esophagogastric Varices, Bleeding, Emergency Room Visits, and Hospitalization Among Patients with Advanced Hepatocellular Carcinoma in the United States: A Retrospective Cohort Study
Parikh ND, Park NJ, Locker M, Chopra I, Yeaw J, Yu S
Journal of Hepatocellular Carcinoma 2025, 12:961-972
Published Date: 15 May 2025
Can Intra-Operative Ablation-Specific Features Based on Ultrasound Fusion Imaging be Used to Predict Early Recurrence of Hepatocellular Carcinoma After Microwave Ablation: A Proof-of-Concept Study
Kang H, Liu Z, Huang B, Liang S, Yang K, Liu H, Lu M, Yan R, Chen X, Xu E
Journal of Hepatocellular Carcinoma 2025, 12:949-960
Published Date: 12 May 2025
Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study
Su K, Liu X, Zeng YC, Xu J, Li H, Wang H, Du S, Wang H, Yue J, Yin Y, Li Z
Journal of Hepatocellular Carcinoma 2025, 12:933-947
Published Date: 9 May 2025
Decoding ARF4 and EIF5B-Based Prognostic Signatures and Immune Landscape Following Insufficient Radiofrequency Ablation in Hepatocellular Carcinoma: Through Multi-Omics and Experimental Validation
Zhang Y, Lu Y, Zheng S, Luo W, Tan M, Luo B
Journal of Hepatocellular Carcinoma 2025, 12:909-931
Published Date: 9 May 2025
NRF1-Induced lncRNA DDX11-AS1 Contributes to the Progression of Hepatocellular Carcinoma via Activating CA9 Expression and the MEK/ERK Pathway
Li Y, Shi M, Bie B, Tian H, Li J, Li Z, Sun J
Journal of Hepatocellular Carcinoma 2025, 12:891-908
Published Date: 7 May 2025
Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-Stage Hepatocellular Carcinoma: A Multi-Institutional Cohort Study in an Asian Population
Chen HK, Chang KC, Shao SC, Soong RS, Chen YC, Wu CF, Wu TH, Chou TS, Chan SC, Lai ECC
Journal of Hepatocellular Carcinoma 2025, 12:879-890
Published Date: 7 May 2025
Post-TACE ALBI-Score Trajectory in Intermediate and Advanced Hepatocellular Carcinoma: Prognostic Implications and Influencing Factors Analysis
Li J, Feng T, Cui C, Wang H, Su T, Jin L, Zhao X, Xiao W
Journal of Hepatocellular Carcinoma 2025, 12:865-878
Published Date: 5 May 2025
Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis
Munker S, Rodriguez I, Bernhart K, Ben Khaled N, Findik M, Siegmund LK, Ye L, Reiter FP, Roessler D, Nasseh D, Balcar L, Pomej K, Scheiner B, Weiss C, Pinter M, Seidensticker M, Mayerle J, Philipp AB, De Toni EN
Journal of Hepatocellular Carcinoma 2025, 12:855-864
Published Date: 5 May 2025
The Synergistic Mechanisms and Prospects of Transarterial Chemoembolization Combined with Immunotherapy for Hepatocellular Carcinoma
Chen QF, Chen S, Zhao M
Journal of Hepatocellular Carcinoma 2025, 12:841-854
Published Date: 30 April 2025
Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma: A Three-Dimensional Visualization Perspective
Tan Y, Li PP, Liu H, Zhu JY, Wu QS
Journal of Hepatocellular Carcinoma 2025, 12:837-840
Published Date: 28 April 2025
The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling
Wang Y, Tan H, Wen C, Chen S, Zheng G, Qi H, Xie L, Shen L, Cao F, Fan W
Journal of Hepatocellular Carcinoma 2025, 12:825-835
Published Date: 26 April 2025
A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma
Zhang Z, Zhao H, Wang P, Geng X, Yin M, Liu Y, Zhang S, Liang Y, Ji J, Zheng G
Journal of Hepatocellular Carcinoma 2025, 12:805-823
Published Date: 18 April 2025
Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network
Cosgrove D, Tan R, Osterland AJ, Hernandez S, Ogale S, Mahrus S, Murphy J, Wilson T, Patton G, Loaiza-Bonilla A, Singal AG
Journal of Hepatocellular Carcinoma 2025, 12:791-804
Published Date: 18 April 2025
Optimizing Treatment Selection for Early Hepatocellular Carcinoma Based on Tumor Biology, Liver Function, and Patient Status
Li X, Xu Y, Ou Y, Li H, Xu W
Journal of Hepatocellular Carcinoma 2025, 12:777-790
Published Date: 16 April 2025
A Novel Nomogram Model for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection
Wu Y, Wang M, Zhang Z, Chen G, Zhang B
Journal of Hepatocellular Carcinoma 2025, 12:765-775
Published Date: 16 April 2025
Prognostic Analysis of Elderly Patients with Hepatocellular Carcinoma: an Exploration and Machine Learning Model Prediction Based on Age Stratification and Surgical Approach
Cai C, Zhu H, Li B, Tang C, Ren Y, Guo Y, Li J, Wang L, Li D, Li D
Journal of Hepatocellular Carcinoma 2025, 12:747-764
Published Date: 14 April 2025
Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit
Wu M, Zou F, He S, Pi Y, Song Y, Chen S, Li L
Journal of Hepatocellular Carcinoma 2025, 12:729-745
Published Date: 13 April 2025
Preoperative Prediction of Macrotrabecular-Massive Hepatocellular Carcinoma Using Machine Learning-Based Ultrasomics
Li Y, Duan S, Ren S, Li D, Ma Y, Bu D, Liu Y, Li X, Cai X, Zhang L
Journal of Hepatocellular Carcinoma 2025, 12:715-727
Published Date: 12 April 2025
Rare Gingival Metastasis Occurring After Conversion Therapy Followed by Resection of Initially Unresectable Hepatocellular Carcinoma: A Case Report
Zhan J, Huang H, Zhan T, Liu X, Cheng Q
Journal of Hepatocellular Carcinoma 2025, 12:705-713
Published Date: 9 April 2025
Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning
Liu Q, Yang Y, Wang Y, Wei S, Yang L, Liu T, Yu Z, Feng Y, Yao P, Zhu Q
Journal of Hepatocellular Carcinoma 2025, 12:685-704
Published Date: 5 April 2025
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab
Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D’Alessio A
Journal of Hepatocellular Carcinoma 2025, 12:671-683
Published Date: 4 April 2025
Machine Learning-Based Model Used for Predicting the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Wu T, Yan J, Xiong F, Liu X, Zhou Y, Ji X, Meng P, Jiang Y, Hou Y
Journal of Hepatocellular Carcinoma 2025, 12:659-670
Published Date: 3 April 2025
Access to Medical Research is a Basic Human Right: A Roadmap to Research Integration Into a Practical Hepatocellular Carcinoma Treatment Allocation Algorithm (HCC-TAA)
Kaseb AO
Journal of Hepatocellular Carcinoma 2025, 12:649-657
Published Date: 28 March 2025
The Expression of Ferroptosis-Related Genes in Hepatocellular Carcinoma and Their Relationships With Prognosis
Li H, Hu X, Wang L, Gu X, Chen S, Tang Y, Chen Y, Chen J, Yuan Z, Wang Y
Journal of Hepatocellular Carcinoma 2025, 12:629-648
Published Date: 20 March 2025
Prediction Model of Survival in Unresectable HCC with Central Bile Duct Invasion Receiving TACE After Biliary Drainage: TEMP Score
Fan W, Zheng X, Zhang W, Zhu B, Wu Y, Xue M, Tang R, Huang Z, Qiao L, Lu M, Wu J, Tang Y, Chen J, Huang S, Bai M, Li J
Journal of Hepatocellular Carcinoma 2025, 12:615-628
Published Date: 20 March 2025
Study on the Mechanism of QRICH1 Mediating PRMT1 to Regulate the Arginine Methylation Modification of cGAS to Promote Arsenics-Induced Pyroptosis in Hepatocellular Carcinoma Cells
Zhang J, Tian T, Tian S, Yao J, Zhang Y, Xie R, Yang T, Han B
Journal of Hepatocellular Carcinoma 2025, 12:597-614
Published Date: 19 March 2025
A Chemotherapy Response-Related Gene Signature and DNAJC8 as Key Mediators of Hepatocellular Carcinoma Progression and Drug Resistance
Ye Y, Zeng Y, Huang S, Zhu C, Wang Q
Journal of Hepatocellular Carcinoma 2025, 12:579-595
Published Date: 20 March 2025
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study
Chen X, Wu X, Peng W, Liu L, Liu X, Wan X, Xu H, Zheng Y, Zhao H, Mao Y, Lu X, Sang X, Chang X, Zhou K, Pan J, Guan M, Hu D, Tan H, Zhang Y, Du S
Journal of Hepatocellular Carcinoma 2025, 12:561-577
Published Date: 19 March 2025
Radiation Segmentectomy or Ablative External Beam Radiation Therapy as Initial Treatment for Solitary Hepatocellular Carcinoma: A Multicenter Experience
De la Garza-Ramos C, Montazeri SA, LeGout JD, Lewis AR, Frey GT, Paz-Fumagalli R, Hallemeier CL, Rutenberg MS, Ashman JB, Toskich BB
Journal of Hepatocellular Carcinoma 2025, 12:553-559
Published Date: 13 March 2025
Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma
Zheng G, Zheng M, Hu P, Zhu Y, Zhang W, Zhang F
Journal of Hepatocellular Carcinoma 2025, 12:539-552
Published Date: 12 March 2025
Efficacy and Safety of Ipilimumab Plus Anti-PD-1/PD-L1 Antibodies Combination Therapy in Advanced Hepatocellular Carcinoma Patients Progressing After Multiple Lines of Treatment: A Retrospective Multicenter Study
Zheng SS, Wu JF, Zhang ZZ, Wu YF, Chen YJ, Qian S, Zhang BH
Journal of Hepatocellular Carcinoma 2025, 12:527-537
Published Date: 11 March 2025
The Diagnostic Performance of AFP, AFP-L3, DCP, CA199, and Their Combination for Primary Liver Cancer
Liu Y, Jiang W, Li X, Zhao H, Wang S
Journal of Hepatocellular Carcinoma 2025, 12:513-526
Published Date: 6 March 2025
Improving Health-Related Quality of Life in Hepatocellular Carcinoma Patients: Key Methodologies for Assessing Patient Reported Outcomes and Intervention Targets
Moon AM, Kappelman MD, Barritt IV AS, Evon DM, Sanoff HK, Wagner LI
Journal of Hepatocellular Carcinoma 2025, 12:497-511
Published Date: 5 March 2025
Prognostic Value of Changes in Combined Child–Pugh Class and ALBI Grade in Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Plus Targeted Therapy and PD-(L)1 Inhibitors
Huang X, Cao X, Kong Y, Tang F, Cong T, Zhou X
Journal of Hepatocellular Carcinoma 2025, 12:481-496
Published Date: 4 March 2025
Research Progress of Liver Cancer Recurrence Based on Energy Metabolism of Liver Cancer Stem Cells
Wu M, Wang H, Wu X, Zeng H, Miao M, Song Y
Journal of Hepatocellular Carcinoma 2025, 12:467-480
Published Date: 3 March 2025
A Case of DEB-TACE Combined with Anlotinib for Treatment of Liver Metastasis from Retroperitoneal Leiomyosarcoma
Cui H, Xu Q, Han Z, Zhang S
Journal of Hepatocellular Carcinoma 2025, 12:459-465
Published Date: 2 March 2025
Efficacy and Safety of Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib for Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven: A Multicentre, Retrospective Propensity Score Matching Analysis
Zhong S, Zhang F, Zhang H, Hu H, Zeng Q, Li Y, Wei Q
Journal of Hepatocellular Carcinoma 2025, 12:445-458
Published Date: 1 March 2025
Integrative Analysis of scRNA-Seq and Bulk RNA-Seq Identifies Plasma Cell Related Genes and Constructs a Prognostic Model for Hepatocellular Carcinoma
Tang M, Xu Y, Pan M
Journal of Hepatocellular Carcinoma 2025, 12:427-444
Published Date: 26 February 2025
Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors
Chen W, Yan HT, Zhang JX, Shen X, Liu J, Liu S, Shi HB, Ding Y, Zu QQ
Journal of Hepatocellular Carcinoma 2025, 12:415-426
Published Date: 27 February 2025
Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon’s Perspective
Zhu XD, Zhao L, Li B, Cheng Y, Sun HC
Journal of Hepatocellular Carcinoma 2025, 12:399-413
Published Date: 26 February 2025
Application of Intravoxel Incoherent Motion in the Prediction of Intra-Tumoral Tertiary Lymphoid Structures in Hepatocellular Carcinoma
Ma L, Liao S, Zhang X, Zhou F, Geng Z, Hu J, Zhang Y, Zhang C, Meng T, Wang S, Xie C
Journal of Hepatocellular Carcinoma 2025, 12:383-398
Published Date: 22 February 2025
Coilin Affects the Prognosis of Hepatocellular Carcinoma Through Cell Cycle and Apoptosis
Lu L, Zhou X, Zheng J, Li D
Journal of Hepatocellular Carcinoma 2025, 12:367-382
Published Date: 21 February 2025
Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients
Zhu D, Tulahong A, Abuduhelili A, Liu C, Aierken A, Lin Y, Jiang T, Lin R, Shao Y, Aji T
Journal of Hepatocellular Carcinoma 2025, 12:353-365
Published Date: 19 February 2025
Outcomes and Prognostic Factors in Cirrhotic Patients with Acute Variceal Bleeding and Hepatocellular Carcinoma: A Nested Case–Control Study
Liu G, Xiao S, Xiang T, Wang X, Shen Y, Yang L, Luo X
Journal of Hepatocellular Carcinoma 2025, 12:343-352
Published Date: 19 February 2025
Comprehensive Analysis of the Role of Heat Shock Proteins in the Immune Microenvironment and Clinical Significance of Hepatocellular Carcinoma
Xiao H, Wang B, Xiong S, Li C, Ding Y, Chao D, Mei B, Shen N, Luo G
Journal of Hepatocellular Carcinoma 2025, 12:325-342
Published Date: 17 February 2025
Apolipoprotein E: A Potential Prognostic and Diagnostic Biomarker for Hepatocellular Carcinoma
Li Y, Lu R, Abuduhailili X, Feng Y
Journal of Hepatocellular Carcinoma 2025, 12:301-324
Published Date: 17 February 2025
Risk Factors and Predictive Analysis of Acute Severe Abdominal Pain After Hepatic Artery Infusion Chemotherapy in Patients with Hepatocellular Carcinoma
Li J, Shi C, Chen J, Zhao Y, Du J, Song J
Journal of Hepatocellular Carcinoma 2025, 12:289-299
Published Date: 17 February 2025
MRI Features and Neutrophil-to-Lymphocyte Ratio (NLR)-Based Nomogram to Predict Prognosis of Microvascular Invasion-Negative Hepatocellular Carcinoma
Wei Y, Huang X, Pei W, Zhao Y, Liao H
Journal of Hepatocellular Carcinoma 2025, 12:275-287
Published Date: 15 February 2025
Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Tao C, Liu L, Hu N, Wang H, Zhang K, Liu Y, Wu F, Wang L, Rong W, Wu J
Journal of Hepatocellular Carcinoma 2025, 12:261-274
Published Date: 15 February 2025
Assessment of Tumor Burden Score as a Feasible and Reliable Tool for Prognosis Prediction for Hepatocellular Carcinoma Undergoing Hepatectomy: A Multicenter, Retrospective Study
Guan R, Zheng Z, Deng M, Mei J, Lin Y
Journal of Hepatocellular Carcinoma 2025, 12:247-260
Published Date: 10 February 2025
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Finn RS, Iyer R, Kalman RS, Parikh ND, Cabrera R, Babajanyan S, Kaseb AO
Journal of Hepatocellular Carcinoma 2025, 12:231-246
Published Date: 7 February 2025
Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
Zhang S, Song R, Hou C, Yao H, Xu J, Zhou H, Li S, Cai W, Fei Y, Meng F, Yin D, Wang J, Zhang S, Liu Y, Wang J, Liu L
Journal of Hepatocellular Carcinoma 2025, 12:219-229
Published Date: 5 February 2025
Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study
Chen S, Qi H, Tan H, Cao F, Xie L, Huang T, Wu Y, Wen C, Wang Y, Shen L, Fan W
Journal of Hepatocellular Carcinoma 2025, 12:205-218
Published Date: 3 February 2025
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
Wang W, Zhang Q, Cui Y, Zhang S, Li B, Xia T, Song Y, Zhou S, Ye F, Xiao W, Cao K, Chi Y, Qu J, Zhou G, Chen Z, Zhang T, Chen X, Ju S, Wang YC
Journal of Hepatocellular Carcinoma 2025, 12:193-203
Published Date: 29 January 2025
The Clinical Characteristics, Patterns of Recurrence, and Long-Term Survival Outcomes of Dual-Phenotype Hepatocellular Carcinoma After Curative Liver Resection
Yu ZC, Fang ZK, Yu Y, Liu SY, Wang KD, Shi ZJ, Jin LM, Huang XK, Lu Y, Shen GL, Liu JW, Huang DS, Zhang CW, Liang L
Journal of Hepatocellular Carcinoma 2025, 12:183-192
Published Date: 30 January 2025
Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus
Li X, Cao K, Fu Z, Chen X, Zhong J, Liu L, Ding N, Zhang X, Qu Z, Zhu L, Zhai J
Journal of Hepatocellular Carcinoma 2025, 12:169-182
Published Date: 25 January 2025
Design and Mechanism Study of 6c, a Novel Artesunate Derivatives, for Anti-Hepatocellular Carcinoma
Xiong SS
Journal of Hepatocellular Carcinoma 2025, 12:149-167
Published Date: 25 January 2025
The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors
Xin Y, Liu N, Peng G, Huang X, Cao X, Zhou X
Journal of Hepatocellular Carcinoma 2025, 12:135-147
Published Date: 24 January 2025
Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular Carcinoma
Zhong L, Peng W, Sun J, Luo Y, Sheng H, Wu Y, Zhou T, Zhou C, Cao C
Journal of Hepatocellular Carcinoma 2025, 12:123-134
Published Date: 22 January 2025
A New Risk Score Based on Lipid Indicators for Patients with Advanced Hepatocellular Carcinoma
Wei X, Guo Z, Zhang T, Liang J
Journal of Hepatocellular Carcinoma 2025, 12:107-121
Published Date: 21 January 2025
Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus
Hatia RI, Hwang LY, Li R, Troisi C, Jalal PK, Amos CI, Gomez HF, Chun YS, Rashid A, Kaseb AO, Scheet PA, Hassan MM
Journal of Hepatocellular Carcinoma 2025, 12:93-106
Published Date: 21 January 2025
A Machine Learning Model for Predicting Prognosis in HCC Patients With Diabetes After TACE
Wu L, Chen L, Zhang L, Liu Y, Ouyang D, Wu W, Lei Y, Han P, Zhao H, Zheng C
Journal of Hepatocellular Carcinoma 2025, 12:77-91
Published Date: 21 January 2025
Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
Song Y, Tian S, Li Z, Miao J, Wu M, Xu T, Wu X, Qiao J, Zhang X, Zhao H, Kang L, Cao L, Zhu P, Miao M
Journal of Hepatocellular Carcinoma 2025, 12:59-76
Published Date: 18 January 2025
Prediction of Pathologic Response in Unresectable Hepatocellular Carcinoma After Downstaging with Locoregional and Systemic Combination Therapy
Yang C, Chen Y, Sheng L, Wang Y, Zhang X, Yang Y, Ronot M, Jiang H, Song B
Journal of Hepatocellular Carcinoma 2025, 12:43-58
Published Date: 16 January 2025
Fully Covered Stent-TIPS for Advanced HCC Patients with Portal Vein Tumor Thrombus-Related Severe Symptomatic Portal Hypertension
Liu Z, Lyu T, Yang J, Xie Y, Fan S, Song L, Zou Y, Wang J
Journal of Hepatocellular Carcinoma 2025, 12:29-41
Published Date: 14 January 2025
Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
Zhang G, Ren Y, Liu J, Cao Y, Xiong F, Liang B, Zheng C, Kan X
Journal of Hepatocellular Carcinoma 2025, 12:15-27
Published Date: 10 January 2025
Correlation Between Dynamic Contrast-Enhanced CT Imaging Signs and Differentiation Grade and Microvascular Invasion of Hepatocellular Carcinoma
Liu Y, Zhou Y, Liao C, Li H, Zhang X, Gong H, Pu H
Journal of Hepatocellular Carcinoma 2025, 12:1-14
Published Date: 8 January 2025
